Article

ThinkLive Cell and Gene Therapy Summit 2024

Explore highlights from the Inaugural ThinkLive Cell and Gene Therapy Summit, which unfolded on May 14-15, 2024. Over two days, global and emerging company leaders, providers, and experts converged at this virtual summit to delve into the future of healthcare. The event served as a platform where over 30 speakers across 10 sessions explored six key focus areas at the forefront of healthcare innovation.

Summit Insights

Dive into a curated selection of insights crafted to deepen your comprehension of the ever-evolving landscape of innovative therapies. From uncovering the latest trends and strategies fueling commercial success to unraveling the complexities of patient access on a global scale, you will find insights and learnings on the forces driving the field forward. 

thinklive

Takeaways from Cencora’s inaugural Cell and Gene Therapy Summit

Lab tech with DNA

Adapting learnings to advance CGT clinical manufacturing

webinar

Leveraging past learnings for future-focused solutions to clinical manufacturing

CGT

Breaking barriers and moving forward: Reflections on impact and future directions for CGT

A light-skinned person with long brown hair holding a tablet and stylus smiles at a colleague during a meeting in a conference room.

A glimpse into the future of CGTs with ARM’s Rita Johnson-Greene
 

Doctor with patient

The power of patient engagement with CGT innovation

The power of patient engagement: A trailblazing journey to elevate access

Protecting your Supply Chain

Tackling the complex nature of the cell and gene therapy supply chain

Navigating the supply chain maze: Overcoming challenges and optimizing logistics for CGTs

Dr Verdun

Navigating the future of CGT: Insights from the FDA

DNA double helix

Unwinding the patient journey: Simplifying experiences and overcoming patient access barriers

Building trust in uncharted territory: Patient considerations for embracing Cell and Gene Therapies

CGT cells

Optimizing channel strategy to overcome CGT-specific barriers

Channel strategy for a rare disease product

Optimizing the channel strategy to expand patient access to cell and gene therapies

Thinking proactively about accessing target markets

Hospital distribution channels

Best practices for building a channel strategy: Lessons learned and forward-thinking initiatives to maximize market reach

Navigating the CGT landscape: Commercial considerations, strategic investments, and effective collaborations
 

Related resources

Article

Harnessing AI and advanced analytics to revolutionize PV signal management
Learn more

Webinar

Navigating global policy shifts: Implications for Europe's pharma landscape
Learn more

Article

The growing case for AI to support pharmacovigilance: World Drug Safety Congress Americas key takeaways
Learn more

Connect with our cell and gene therapy team

Schedule some time with our cell and gene therapy experts today. We look forward to hearing from you.